Delivery Order SPE2DR25D3504-SPE2DR26F7DB4
Award Date 2/6/26
Potential Completion Date 2/9/26
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for $2,550.48 to supply Quillivant XR 25 mg/5 ml suspension (60 ml). Place of performance is Conshohocken, PA. The ultimate completion date is February 9, 2026. This is a firm fixed-price delivery order with no set-aside. The order was issued under the DLA Troop Support Medical IDC, an indefinite delivery contract supporting pharmaceutical and medical supply procurement for military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...
- On January 14, 2026, the Defense Logistics Agency awarded a delivery order valued at $5,373.26 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension (60 ml). The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Performance will be conducted at the awardee's location in Conshohocken, Pennsylvania, with an ultimate completion date of January 15, 2026. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on January 29, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml quantities, with a contract ceiling value of $2,916.42 and a completion date of January 30, 2026. This is a firm fixed-price, non-set-aside award executed as a child delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $1,723.93 delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by January 27, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 180 ml quantity, with a ceiling value of $1,809.72. This is a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities, with a ceiling value of $2,489.92 and an ultimate completion date of January 26, 2026. The contract employs firm fixed pricing and represents a non-competitive delivery order placed under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,939.44 to supply Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, with a completion date of December 24, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency (DLA) awarded a $1,347.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp. for the supply of 150 mL bottles of the pharmaceutical product Quillivant XR 25 mg/5 mL suspension. This order is a part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in a 150 ml quantity, valued at $1,807.02. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The order is scheduled for completion by June 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...